The global burden of chronic obstructive pulmonary disease, number 3, The natural history of chronic obstructive pulmonary disease

被引:187
作者
Mannino, DM
Watt, G
Hole, D
Gillis, C
Hart, C
McConnachie, A
Smith, GD
Upton, M
Hawthorne, V
Sin, DD
Man, SFP
Van Eeden, S
Mapel, DW
Vestbo, J
机构
[1] Univ Kentucky, Div Pulm & Crit Care Med, Med Ctr, Lexington, KY 40536 USA
[2] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland
[4] Univ Bristol, Bristol BS8 1TH, Avon, England
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[6] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England
[7] Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark
关键词
D O I
10.1183/09031936.06.00024605
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive Pulmonary disease (COPD) is a leading cause of morbidity and mortality in the USA, and it remains one of the few diseases that continues to increase its numbers. The development and progression of COPD can vary dramatically between individuals. A low level of lung function remains the cornerstone of COPD diagnosis and is a key predictor of prognosis. Lung function, however, is not the only factor in determining morbidity and mortality related to COPD, with factors such as body mass index, exercise capability and comorbid disease being important predictors of poor outcomes. Exacerbations of COPD are additional important indicators of both quality of life and Outcomes in COPD patients. Definitions of exacerbations can vary, ranging from an increase in symptoms to COPD-related hospitalisations and death. COPD exacerbations are more common in patients with lower levels Of lung function and may lead to more rapid declines in lung function. Better Understanding of the natural history of COPD may lead to better definitions of specific COPD phenotypes, better interventions and improved outcomes.
引用
收藏
页码:627 / 643
页数:17
相关论文
共 65 条
[21]  
Hole DJ, 1996, BRIT MED J, V313, P711
[22]   Usefulness of GOLD classification of COPD severity [J].
Köhler, D ;
Fischer, J ;
Raschke, F ;
Schönhofer, B .
THORAX, 2003, 58 (09) :825-825
[23]   The genetics of chronic obstructive pulmonary disease [J].
Lomas, DA ;
Silverman, EK .
RESPIRATORY RESEARCH, 2001, 2 (01) :20-26
[24]   Atherosclerosis [J].
Lusis, AJ .
NATURE, 2000, 407 (6801) :233-241
[25]   Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination [J].
Mannino, DM ;
Ford, ES ;
Redd, SC .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (06) :540-547
[26]   COPD - Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity [J].
Mannino, DM .
CHEST, 2002, 121 (05) :121S-126S
[27]   Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow up study [J].
Mannino, DM ;
Buist, AS ;
Petty, TL ;
Enright, PL ;
Redd, SC .
THORAX, 2003, 58 (05) :388-393
[28]   Low lung function and incident lung cancer in the United States - Data from the First National Health and Nutrition Examination Survey follow-up [J].
Mannino, DM ;
Aguayo, SM ;
Petty, TL ;
Redd, SC .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (12) :1475-1480
[29]   Obstructive and restrictive lung disease and markers of inflammation: Data from the Third National Health and Nutrition Examination [J].
Mannino, DM ;
Ford, ES ;
Redd, SC .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (09) :758-762
[30]  
MANNINO DM, 2002, MMWR-MORBID MORTAL W, V51, P1